These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17990706)

  • 1. Cystic fibrosis.
    Geddes D
    Clin Med (Lond); 2007 Oct; 7(5):445-6. PubMed ID: 17990706
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonology: CFTR modulators for cystic fibrosis.
    Bertoncini E; Colomb-Lippa D
    JAAPA; 2013 Feb; 26(2):59-60. PubMed ID: 23409389
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.
    Zach MS
    Thorax; 1996 Jul; 51(7):750-5. PubMed ID: 8882085
    [No Abstract]   [Full Text] [Related]  

  • 4. CT imaging of pediatric patients with cystic fibrosis on ivacaftor therapy.
    Hayes D; Long FR; McCoy KS; Sheikh SI
    Lung; 2014 Oct; 192(5):823-4. PubMed ID: 25099273
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene therapy for cystic fibrosis: challenges and future directions.
    Wilson JM
    J Clin Invest; 1995 Dec; 96(6):2547-54. PubMed ID: 8675618
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in Lung Clearance Index in Preschool-aged Patients with Cystic Fibrosis Treated with Ivacaftor (GOAL): A Clinical Trial.
    Ratjen F; Klingel M; Black P; Powers MR; Grasemann H; Solomon M; Sagel SD; Donaldson SH; Rowe SM; Rosenfeld M
    Am J Respir Crit Care Med; 2018 Aug; 198(4):526-528. PubMed ID: 29614238
    [No Abstract]   [Full Text] [Related]  

  • 7. Cystic fibrosis.
    Welsh MJ; Smith AE
    Sci Am; 1995 Dec; 273(6):52-9. PubMed ID: 8525348
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene therapy trial for cystic fibrosis shows modest benefits.
    Hawkes N
    BMJ; 2015 Jul; 351():h3608. PubMed ID: 26141073
    [No Abstract]   [Full Text] [Related]  

  • 9. Cystic fibrosis. Growing pains.
    Bryan J
    Health Serv J; 2000 Jan; 110(5689):suppl 6-7. PubMed ID: 11184399
    [No Abstract]   [Full Text] [Related]  

  • 10. Cystic fibrosis.
    Curr Opin Pulm Med; 1996 Nov; 2(6):B109-15. PubMed ID: 9363194
    [No Abstract]   [Full Text] [Related]  

  • 11. Excitement mounts for first disease-modifying cystic fibrosis drugs.
    Opar A
    Nat Rev Drug Discov; 2011 Jul; 10(7):479-80. PubMed ID: 21720393
    [No Abstract]   [Full Text] [Related]  

  • 12. Adult cystic fibrosis: a new therapeutic challenge for the primary care physician.
    Bria WF; Kenny WR
    J Med Assoc Ga; 1979 Oct; 68(10):912-4. PubMed ID: 501230
    [No Abstract]   [Full Text] [Related]  

  • 13. The immediate effect of physiotherapy and aerosol treatment on pulmonary function in children with cystic fibrosis.
    Kerrebijn KF; Veentjer R; Bonzet-vd Water E
    Eur J Respir Dis; 1982 Jan; 63(1):35-42. PubMed ID: 7067754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives in cystic fibrosis.
    Gurwitz D; Corey M; Francis PW; Crozier D; Levison H
    Pediatr Clin North Am; 1979 Aug; 26(3):603-15. PubMed ID: 492796
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhaled hypertonic saline as a therapy for cystic fibrosis.
    Elkins MR; Bye PT
    Curr Opin Pulm Med; 2006 Nov; 12(6):445-52. PubMed ID: 17053496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [25th European conference on cystic fibrosis. Genova, June 2002].
    Apor P; Csiszér E
    Orv Hetil; 2002 Sep; 143(36):2109-10. PubMed ID: 12378902
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of cystic fibrosis with aerosols].
    Kerrebijn KF
    Maandschr Kindergeneeskd; 1969 Nov; 37(5):125-31. PubMed ID: 5361958
    [No Abstract]   [Full Text] [Related]  

  • 18. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
    Kuk K; Taylor-Cousar JL
    Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained Benefit from ivacaftor demonstrated by combining clinical trial and cystic fibrosis patient registry data.
    Sawicki GS; McKone EF; Pasta DJ; Millar SJ; Wagener JS; Johnson CA; Konstan MW
    Am J Respir Crit Care Med; 2015 Oct; 192(7):836-42. PubMed ID: 26132840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New cystic fibrosis drug paves the way for orphan diseases.
    Cooney D
    Lancet Respir Med; 2013 Apr; 1(2):104. PubMed ID: 24429084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.